BLRX

NASDAQ HEALTHCARE

BioLineRx Ltd

$2.01

-$0.04 (-1.95%)

Live quote

52w: $1.95 – $3.95

Loading chart…

P/E Ratio—

P/B Ratio292.71

EV/EBITDA—

Debt/Equity—

ROE-11.13%

ROIC—

Revenue Growth-95.92%

Gross Margin80.51%

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.

Create a free account to add BLRX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.